Authors: HENRY D ELLISON W SULLIVAN J MANSFIELD DL MAGNER DJ DORR MB TALBOT GH

Citation: D. Henry et al., TREATMENT OF COMMUNITY-ACQUIRED ACUTE UNCOMPLICATED URINARY-TRACT INFECTION WITH SPARFLOXACIN VERSUS OFLOXACIN, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2262-2266

Authors: BRON NJ DORR MB MANT TG WEBB CL VASSOS AB

Citation: Nj. Bron et al., THE TOLERANCE AND PHARMACOKINETICS OF CLINAFLOXACIN (CI-960) IN HEALTHY-SUBJECTS, Journal of antimicrobial chemotherapy, 38(6), 1996, pp. 1023-1029

Authors: PENTIKIS HS JOHNSON RD HUANG MY JENSEN BK HEALD DL DORR MB TALBOT GH

Citation: Hs. Pentikis et al., POPULATION PHARMACOKINETIC ANALYSIS OF SPARFLOXACIN PLASMA-CONCENTRATIONS OBTAINED IN PHASE-III CLINICAL-TRIALS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 70-70

Authors: BRUNO R DORR MB MONTAY G FRYDMAN A THIS F FUMOLEAU P KAY S KAVANAGH GH BURRIS HA RIGAS JR BAYSSAS M

Citation: R. Bruno et al., DESIGN AND PROSPECTIVE IMPLEMENTATION OF POPULATION PHARMACOKINETIC STUDIES DURING THE DEVELOPMENT OF DOCETAXEL (D) (RP-56976) - A NEW ANTICANCER DRUG, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 161-161